Published in Biochem Biophys Res Commun on May 19, 1998
Extracellular calcium elicits a chemokinetic response from monocytes in vitro and in vivo. J Clin Invest (2000) 1.11
Calcium nutrition and extracellular calcium sensing: relevance for the pathogenesis of osteoporosis, cancer and cardiovascular diseases. Nutrients (2013) 0.94
Extracellular calcium as an integrator of tissue function. Int J Biochem Cell Biol (2008) 0.93
The calcium-sensing receptor in bone. J Bone Miner Metab (2008) 0.92
Is the calcium receptor a molecular target for the actions of strontium on bone? Osteoporos Int (2003) 0.90
Osteoblast calcium-sensing receptor has characteristics of ANF/7TM receptors. J Cell Biochem (2005) 0.89
Total calcium-sensing receptor expression in circulating monocytes is increased in rheumatoid arthritis patients with severe coronary artery calcification. Arthritis Res Ther (2014) 0.81
The calcium-sensing receptor in bone metabolism: from bench to bedside and back. Osteoporos Int (2015) 0.81
Calcium-sensing receptor: A new target for therapy of diarrhea. World J Gastroenterol (2016) 0.80
The role of the calcium-sensing receptor in gastrointestinal inflammation. Semin Cell Dev Biol (2015) 0.77
Calcium sensing receptor activation elevates proinflammatory factor expression in human adipose cells and adipose tissue. Mol Cell Endocrinol (2012) 0.77
Determination and modulation of total and surface calcium-sensing receptor expression in monocytes in vivo and in vitro. PLoS One (2013) 0.77
Osteoblastic cells regulate the haematopoietic stem cell niche. Nature (2003) 19.60
Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science (2000) 10.81
Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature (1993) 7.89
Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol (2000) 6.90
Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell (1993) 4.13
A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med (1996) 3.20
CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol Cell Biol (1998) 3.19
A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet (1995) 3.18
Stem cell repopulation efficiency but not pool size is governed by p27(kip1). Nat Med (2000) 3.15
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 2.69
Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab (1996) 2.33
Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation. Nat Genet (1994) 2.23
Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis. Pharmacogenomics J (2007) 2.17
Polycystin-L is a calcium-regulated cation channel permeable to calcium ions. Nature (1999) 2.17
Molecular cloning and characterization of a channel-like transporter mediating intestinal calcium absorption. J Biol Chem (1999) 2.16
Expression of an extracellular calcium-sensing receptor in human and mouse bone marrow cells. J Bone Miner Res (1997) 2.11
Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials. Arch Dermatol (2000) 2.09
Mother knows best. Nat Med (1998) 2.07
Notch1-induced delay of human hematopoietic progenitor cell differentiation is associated with altered cell cycle kinetics. Blood (1999) 2.02
L-amino acid sensing by the extracellular Ca2+-sensing receptor. Proc Natl Acad Sci U S A (2000) 2.02
Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells. J Biol Chem (1998) 1.98
Implications on clinical scenario of gold nanoparticle radiosensitization in regards to photon energy, nanoparticle size, concentration and location. Phys Med Biol (2011) 1.98
Functional isolation and characterization of human hematopoietic stem cells. Science (1995) 1.92
Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipient. N Engl J Med (1998) 1.92
Active movement of T cells away from a chemokine. Nat Med (2000) 1.87
Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chem (1995) 1.86
Interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B-cell lymphoma. Blood (1995) 1.84
CXCR-4 desensitization is associated with tissue localization of hemopoietic progenitor cells. J Immunol (2001) 1.77
The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. J Antimicrob Chemother (2007) 1.72
Efficient generation of human T cells from a tissue-engineered thymic organoid. Nat Biotechnol (2000) 1.72
Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor. J Clin Endocrinol Metab (2000) 1.71
Intercellular communication mediated by the extracellular calcium-sensing receptor. Nat Cell Biol (2000) 1.68
Localization of the extracellular Ca2+/polyvalent cation-sensing protein in rat kidney. Am J Physiol (1998) 1.62
Cloning and functional expression of a rat kidney extracellular calcium/polyvalent cation-sensing receptor. Proc Natl Acad Sci U S A (1995) 1.61
Production of tumor necrosis factor alpha and interleukin 1 beta by monocytic cells infected with human immunodeficiency virus. J Clin Invest (1989) 1.61
Clostridium difficile in acute and long-stay elderly patients. Age Ageing (1988) 1.60
Expression and characterization of inactivating and activating mutations in the human Ca2+o-sensing receptor. J Biol Chem (1996) 1.59
Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. J Clin Invest (1997) 1.59
Nomenclature of the proteins of cows' milk--sixth revision. J Dairy Sci (2004) 1.55
Calcium-regulated renal calcium handling in healthy men: relationship to sodium handling. J Clin Endocrinol Metab (1998) 1.55
Temporal mapping of gene expression levels during the differentiation of individual primary hematopoietic cells. Proc Natl Acad Sci U S A (1996) 1.51
Polycystin-2 is a novel cation channel implicated in defective intracellular Ca(2+) homeostasis in polycystic kidney disease. Biochem Biophys Res Commun (2001) 1.48
Hematopoietic growth factors. Biology and clinical applications. N Engl J Med (1989) 1.48
Four-parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue. J Clin Endocrinol Metab (1983) 1.45
Interferon therapy for Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS) Ann Intern Med (1989) 1.45
Extravasation of liposomal daunorubicin in patients with AIDS-associated Kaposi's sarcoma: a report of four cases. Oncol Nurs Forum (1998) 1.44
Assessment of frequency-dependent alterations in the level of extracellular Ca2+ in the synaptic cleft. Biophys J (1997) 1.38
Familial hypocalciuric hypercalcemia: recognition among patients referred after unsuccessful parathyroid exploration. Ann Intern Med (1980) 1.37
Role of anions in parathyroid hormone release from dispersed bovine parathyroid cells. Proc Natl Acad Sci U S A (1978) 1.36
The gene responsible for familial hypocalciuric hypercalcemia maps to chromosome 3q in four unrelated families. Nat Genet (1992) 1.35
Chronic arsenic toxicity from drinking tubewell water in rural West Bengal. Bull World Health Organ (1988) 1.33
Human calcium transport protein CaT1. Biochem Biophys Res Commun (2000) 1.33
Circulating parathyroid hormone activity: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. J Clin Endocrinol Metab (1978) 1.33
Identification and localization of extracellular Ca(2+)-sensing receptor in rat intestine. Am J Physiol (1998) 1.33
Reoperative parathyroid surgery for persistent hyperparathyroidism. Surgery (1978) 1.32
Divalent cation metabolism. Familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. Am J Med (1978) 1.32
CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo. J Pharmacol Exp Ther (1999) 1.31
Activating mutations of the calcium-sensing receptor: management of hypocalcemia. J Clin Endocrinol Metab (2001) 1.31
Human immunodeficiency virus does not induce interleukin-1, interleukin-6, or tumor necrosis factor in mononuclear cells. J Virol (1990) 1.28
Parathyroid cell surface autoantibodies that inhibit parathyroid hormone secretion from dispersed human parathyroid cells. J Bone Miner Res (1986) 1.27
Functional characterization of calcium-sensing receptor mutations expressed in human embryonic kidney cells. J Clin Invest (1996) 1.27
Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma. J Clin Oncol (1996) 1.27
The parathyroid hormone circadian rhythm is truly endogenous--a general clinical research center study. J Clin Endocrinol Metab (1997) 1.26
Up-regulation of the parathyroid calcium-sensing receptor after burn injury in sheep: a potential contributory factor to postburn hypocalcemia. Crit Care Med (2000) 1.25
Mouse osteoblastic cell line (MC3T3-E1) expresses extracellular calcium (Ca2+o)-sensing receptor and its agonists stimulate chemotaxis and proliferation of MC3T3-E1 cells. J Bone Miner Res (1998) 1.24
Localization of the extracellular Ca(2+)-sensing receptor and PTH/PTHrP receptor in rat kidney. Am J Physiol (1996) 1.23
Transforming growth factor beta 1 mediates cell-cycle arrest of primitive hematopoietic cells independent of p21(Cip1/Waf1) or p27(Kip1). Blood (2001) 1.23
Intrinsic human immunodeficiency virus type 1 resistance of hematopoietic stem cells despite coreceptor expression. J Virol (1999) 1.23
Preparation of viable isolated bovine parathyroid cells. Endocrinology (1976) 1.22
Racial differences in parathyroid hormone dynamics. J Clin Endocrinol Metab (1994) 1.22
Filamin-A binds to the carboxyl-terminal tail of the calcium-sensing receptor, an interaction that participates in CaR-mediated activation of mitogen-activated protein kinase. J Biol Chem (2001) 1.22
Regulation of MAP kinase by calcium-sensing receptor in bovine parathyroid and CaR-transfected HEK293 cells. Am J Physiol Renal Physiol (2001) 1.21
The Ca2+-sensing receptor: a target for polyamines. Am J Physiol (1997) 1.21
Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. J Clin Invest (2001) 1.20
Calcitonin-secreting cells of the thyroid express an extracellular calcium receptor gene. Endocrinology (1995) 1.20
Expression of messenger ribonucleic acids encoding a parathyroid hormone-like peptide in normal human and animal tissues with abnormal expression in human parathyroid adenomas. Mol Endocrinol (1988) 1.18
Beta-Adrenergic receptor interactions. Direct comparison of receptor interaction and biological activity. J Biol Chem (1976) 1.17
Sodium and ionic strength sensing by the calcium receptor. J Biol Chem (1998) 1.17
Family studies in patients with primary parathyroid hyperplasia. Am J Med (1977) 1.17
Extracellular calcium-sensing receptor expression and its potential role in regulating parathyroid hormone-related peptide secretion in human breast cancer cell lines. Endocrinology (2000) 1.17